300 related articles for article (PubMed ID: 19659473)
21. Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting.
Kardos M; Kimball AB
J Am Acad Dermatol; 2012 Jan; 66(1):148-52. PubMed ID: 22177633
[TBL] [Abstract][Full Text] [Related]
22. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis.
Murakami S; Takeno M; Kirino Y; Kobayashi M; Watanabe R; Kudo M; Ihata A; Ueda A; Ohno S; Watanuki Y; Kaneko T; Ishigatsubo Y
Tuberculosis (Edinb); 2009 Mar; 89(2):136-41. PubMed ID: 19211305
[TBL] [Abstract][Full Text] [Related]
23. Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis.
Inanc N; Aydin SZ; Karakurt S; Atagunduz P; Yavuz S; Direskeneli H
J Rheumatol; 2009 Dec; 36(12):2675-81. PubMed ID: 19918035
[TBL] [Abstract][Full Text] [Related]
24. Tuberculosis screening prior to anti-tumor necrosis factor therapy among patients with immune-mediated inflammatory diseases in Japan: a longitudinal study using a large-scale health insurance claims database.
Tomio J; Yamana H; Matsui H; Yamashita H; Yoshiyama T; Yasunaga H
Int J Rheum Dis; 2017 Nov; 20(11):1674-1683. PubMed ID: 29076252
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan.
Chiu HY; Hsueh PR; Tsai TF
Br J Dermatol; 2011 Mar; 164(3):553-9. PubMed ID: 21083541
[TBL] [Abstract][Full Text] [Related]
26. The 'either test positive' strategy for latent tuberculous infection before anti-tumour necrosis factor treatment.
Jung YJ; Lee JY; Jo KW; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS
Int J Tuberc Lung Dis; 2014 Apr; 18(4):428-34. PubMed ID: 24670697
[TBL] [Abstract][Full Text] [Related]
27. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay.
Jong Lee K; Ae Kang Y; Mi Kim Y; Cho SN; Wook Moon J; Suk Park M; Kyu Kim S; Chang J; Sam Kim Y
Scand J Infect Dis; 2010 Sep; 42(9):672-8. PubMed ID: 20482459
[TBL] [Abstract][Full Text] [Related]
28. Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers.
Cobanoglu N; Ozcelik U; Kalyoncu U; Ozen S; Kiraz S; Gurcan N; Kaplan M; Dogru D; Yalcin E; Pekcan S; Kose M; Topaloglu R; Besbas N; Bakkaloglu A; Kiper N
Int J Tuberc Lung Dis; 2007 Nov; 11(11):1177-82. PubMed ID: 17958978
[TBL] [Abstract][Full Text] [Related]
29. Acquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People's Republic of China.
Li CR; Mao QX; Chen M; Jia WX; Yao X; Feng SY; Jia H; Gong JQ; Yang XY
Drug Des Devel Ther; 2015; 9():5591-4. PubMed ID: 26508833
[TBL] [Abstract][Full Text] [Related]
30. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak.
Lee SH; Lew WJ; Kim HJ; Lee HK; Lee YM; Cho CH; Lee EJ; Lee DY; Ryu SW; Oh SY; Kim SO; Shim TS
Respir Med; 2010 Mar; 104(3):448-53. PubMed ID: 19879123
[TBL] [Abstract][Full Text] [Related]
31. Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands.
Erkens CG; Dinmohamed AG; Kamphorst M; Toumanian S; van Nispen-Dobrescu R; Alink M; Oudshoorn N; Mensen M; van den Hof S; Borgdorff M; Verver S
Int J Tuberc Lung Dis; 2014 Apr; 18(4):413-20. PubMed ID: 24670695
[TBL] [Abstract][Full Text] [Related]
32. Use of interferon-gamma release assay for latent tuberculosis infection screening in older adults exposed to tuberculosis in a nursing home.
Katsenos S; Nikolopoulou M; Gartzonika C; Manda-Stachouli C; Gogali A; Grypaiou C; Mavridis A; Constantopoulos SH; Daskalopoulos G
J Am Geriatr Soc; 2011 May; 59(5):858-62. PubMed ID: 21517785
[TBL] [Abstract][Full Text] [Related]
33. Is tuberculin skin testing reliable during anti-tumor necrosis factor-alfa therapy? A case report and review of the literature.
Haddican MM; Koo JY
J Am Acad Dermatol; 2011 Jul; 65(1):195-7. PubMed ID: 21507516
[TBL] [Abstract][Full Text] [Related]
34. Interferon gamma release assays: principles and practice.
Lalvani A; Pareek M
Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
[TBL] [Abstract][Full Text] [Related]
36. Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries?
Abud-Mendoza C; Martínez-Martínez MU; DE Jesús Macías-Mendoza J; Magaña-Aquino M
J Rheumatol; 2010 Mar; 37(3):672-3; author reply 673. PubMed ID: 20197567
[No Abstract] [Full Text] [Related]
37. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
[TBL] [Abstract][Full Text] [Related]
38. Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases.
Papay P; Eser A; Winkler S; Frantal S; Primas C; Miehsler W; Angelberger S; Novacek G; Mikulits A; Vogelsang H; Reinisch W
Eur J Clin Invest; 2011 Oct; 41(10):1071-6. PubMed ID: 21413978
[TBL] [Abstract][Full Text] [Related]
39. Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis.
Jo KW; Hong Y; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee SD; Kim WS; Kim DS; Shim TS
Respir Med; 2013 Nov; 107(11):1797-802. PubMed ID: 24029000
[TBL] [Abstract][Full Text] [Related]
40. Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report.
Malaviya AN; Kapoor S; Garg S; Rawat R; Shankar S; Nagpal S; Khanna D; Furst DE
J Rheumatol; 2009 Jul; 36(7):1414-20. PubMed ID: 19487263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]